Epstein-Barr virus (EBV) utilizes a completely different mode of DNA replication during the lytic cycle than that employed during latency. The latency origin of replication, ori-P, which functions in the replication of the latent episomal form of the EBV genome, requires only a single virally encoded protein, EBNA-1, for its activity. During the lytic cycle, a separate origin, ori-Lyt, is utilized. Relatively little is known about the trans-acting proteins involved in ori-Lyt replication. We established a cotransfection-replication assay to identify EBV genes whose products are required for replication of ori-Lyt. In this assay, a BamHI-H plasmid containing ori-Lyt was replicated in Vero cells cotransfected with the BamHI-H target, the three EBV lytic-cycle transactivators Zta, Rta, and Mta, and the EBV genome provided in the form of a set of six overlapping cosmid clones. By removing individual cosmids from the cotransfection mixture, we found that only three of the six cosmids were necessary for ori-Lyt replication. Subcloning of the essential cosmids led to the identification of six EBV genes that encode replication proteins. These genes and their functions (either known or predicted on the basis of sequence comparison with herpes simplex virus) are BALF5, the DNA polymerase; BALF2, the single-stranded DNA-binding protein homolog; BMRF1, the DNA polymerase processivity factor; BSLF1 and BBLF4, the primase and helicase homologs; and BBLF2/3, a potential homolog of the third component of the helicase-primase complex. In addition, ori-Lyt replication in this cotransfection assay was also dependent on one or more genes provided by the EBV SalI-F fragment and on the three lytic-cycle transactivators Zta, Rta, and Mta.
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Epstein-Barr virus (EBV)
, like all herpesviruses, has both a latent state and a lytic replicative cycle. In latently infected B cells, multiple copies of the viral genome are maintained predominantly as nucleosome-covered episomes that are replicated in synchrony with cell division (73) . Latency replication proceeds from ori-P, which is composed of two domains (72) . Region I, the family of repeats, contains 20 tandemly repeated binding sites for EBNA-1 (57) and functions as an EBNA-1-dependent enhancer whose activity is important for both ori-P replication and transcriptional activation of the BamHI-C latency promoter (58, 63, 71) . Region II, the dyad symmetry, contains two pairs of overlapping EBNA-1-binding sites (57) and is the site of initiation of latency replication (26) . EBNA-1 is the only virally encoded protein required for replication of the episomal EBV genome, all other proteins, including the DNA polymerase, being provided by the host cell (74) .
Lytic EBV replication occurs in mucosal epithelial cells of the oropharynx and genital tract (60) and can be activated in latently infected B cells in culture by treatment with phorbol esters (77), by superinfection with the P3HR-1 strain which carries defective rearranged viral genomes (53) , or by introduction of the EBV Zta transactivator (13) . Because of the limitations imposed by the lack of an EBV-infectable epithelial culture system, information on EBV lytic viral replication has been obtained predominantly in B-cell cultures undergoing reactivation. In this system, the transition from latency to a lytic replicative cycle is mediated by three viral regulatory proteins, the Zta (BZLF1, EB1, or ZEBRA) and Rta (BRLF1) transcriptional transactivators (9, 12, 13, 31, * Corresponding author. 34, 48) and Mta (BMLF1), which has a posttranscriptional mechanism of action (5, 39, 49) . The concerted action of these three proteins results in activation of the complete cascade of early and late EBV gene expression.
Lytic DNA replication proceeds from a separate origin, ori-Lyt, and results in 100-to 1,000-fold amplification of the genome via concatemeric intermediates (18, 32, 59 ). In the prototype EBV genome, there are two copies of ori-Lyt, one in DS-L and one in DS-R. However, one copy is sufficient for lytic-cycle replication as exemplified by the EBV strain B95-8, which contains only DS-L. ori-Lyt covers 690 bp and can be divided into three essential domains. (i) The first domain is the promoter and leader of the BHLF1 gene whose transcript is the most abundantly synthesized of the lyticcycle mRNAs (38) . (In the DS-R origin, this promoter controls the related PstI repeat gene.) The BHLF1 promoter contains four binding sites for the Zta transactivator and is strongly Zta responsive in transient expression assays (47, 48) . (ii) The second domain is a central 225-bp region whose prominent features include two related AT-rich palindromes of 18 and 20 bp and an adjacent polypurine-polypyrimidine tract. Elements of this type destabilize helical structure and may serve as sites for the initiation or transmission of localized unwinding in origins of replication (42, 68) . (iii) The third domain is a powerful enhancer element that responds to the Rta transactivator and contains two binding sites for Rta and one for Zta (14, 31, 48) . Hammerschmidt and Sugden (32) found that origin function was retained when this enhancer was replaced with the enhancer from the human cytomegalovirus (HCMV) major immediate-early gene, suggesting that it was enhancer function per se that was provided by this region rather than a contribution involving specific protein interactions.
The lytic origins of replication have been identified for a number of herpesviruses, including HCMV and simian cytomegalovirus (SCMV) (2, 33) , varicella-zoster virus (VZV) (17) , pseudorabies virus (43), equine herpesvirus 1 (4), Marek's disease virus (7) , and herpes simplex virus (HSV) (51, 62, 67) . Of these herpesviruses, replication of HSV has been the most extensively characterized. The HSV viral proteins involved in DNA replication were originally recognized through genetic studies (reviewed in reference 66). Subsequently, a complete set of seven essential genes was identified by Challberg et al. (8, 52, 70) 
RESULTS
Establishment of an ori-Lyt replication assay. To identify viral proteins required to replicate ori-Lyt, we established a transient cotransfection assay similar to that described by Challberg (8) for HSV type 1 (HSV-1). In that assay, large restriction fragments of the HSV-1 genome were cotransfected into Vero cells with a plasmid containing the HSV-1 origin of replication, ori-S, and DpnI sensitivity was used to discriminate between input and replicated DNA (55) . The DpnI assay is based on the differential ability of DpnI to cleave the input bacterially synthesized DNA which is methylated on the A residue of the DpnI cleavage site GATC and the lack of cleavage when this methylation is lost after replication in eukaryotic cells. In the experiments described here, Vero cells (an African green monkey kidney cell line) were also used, and the exogenous EBV genome was provided by a set of six overlapping cosmids from the EBV strain M-ABA (56) (Fig. 1) . The replication origin was provided by a plasmid carrying the EBV BamHI-H fragment which encompasses the DS-L ori-Lyt. The transfection mixture also contained expression plasmids for the lyticcycle transactivators, Zta, Rta, and Mta, to ensure adequate expression of the EBV early genes from the transfected cosmid clones. To determine the optimal assay conditions, we transfected Vero cells with the complete set of cosmids, the BamHI-H target, and increasing amounts (0 to 2.5 ,ug) of the expression plasmids encoding the transactivators. The isolated cellular DNA was cleaved with restriction enzymes, and the DNA fragments were separated by gel electrophoresis and transferred onto a nylon membrane. The input, transfected DNA was visualized by hybridization with a radiolabeled pBR322 probe. The BamHI-cleaved DNA is shown in Fig. 2A , and BamHI-plus-DpnI-cleaved DNA is shown in Fig. 2B . At a concentration of 2.5 ,ug of each expression plasmid, maximal replication of the target occurred (lane 4), as indicated by the presence of the DpnIresistant ori-Lyt band (arrowed). If no transactivators were included, no detectable replication occurred (lane 1). Below 2.5 ,ug of the transactivators, either no detectable replication occurred (lane 2) or minimal replication of the target occurred (lane 3). Replication was origin specific. Of all the input DNAs, only the BamHI-H target (and to a lesser extent the cosmids that contain DS-R and DS-L) showed DpnI resistance.
Replication genes are located on three separate cosmids. Having established the assay conditions, we next determined whether any of the cosmids were dispensable. The assay was repeated with one of the cosmids being omitted from each transfection mix (Fig. 3B) ori-Lyt, we cotransfected them with expression plasmids for Zta, Rta, and Mta. Efficient replication of the target occurred in the presence of these three cosmids (Fig. 4) Lane 2, no Zta added. Lane 3, the cosmid cMB14 was replaced by the cosmid cMSalC. Lane 4, the cosmid cMB14 was replaced by expression plasmids encoding BMRF1, the polymerase processivity factor, and BSLF1, the primase homolog. (C) Lane 1, the three cosmids, cMB14, cM301-99, and cM302-21, plus the transactivator expression plasmids. Lane 2, no Zta added. Lane 3, the cosmid cM302-21 was replaced by expression plasmids encoding BALF5, the DNA polymerase, and BALF2, the single-stranded DNA-binding protein homolog. Lane 4 , minus BALF5. Lane 5, minus BALF2. and UL52; the DNA polymerase processivity factor, UL42; and the origin-binding protein, UL9. Table 1 shows the seven HSV-1 replication genes, their potential EBV homologs, and the percent homology which they share (52) .
Upon inspection of the map location of those EBV genes that had potential homology with the HSV-1 replication genes, it became apparent that they were all located within the three cosmids that were essential for replication in our assay. To determine whether these genes indeed encoded functional replication proteins, the EBV DNA polymerase, BALFS, and its processivity factor, BMRF1, as well as BSLF1, BBLF4, and BALF2 were placed under the control of the strong simian virus 40 early or CMV major immediateearly promoters in eukaryotic expression vectors and tested in substitution experiments. First, the cosmid cMB14 was replaced with another cosmid, cMSalC, which has five open reading frames in common with cMB14. This cosmid was able to substitute functionally for cMB14 (Fig. 5B, lane 3) , indicating that the replication genes provided by cMB14 were located within the region that overlaps with cMSalC. The common sequences contain BMRF1 and BSLF1 plus BMLF1 (Mta), BMRF2 (a late gene), and BORF2 and BaRF1, which encode the large and small subunits of ribonucleotide reductase (3, 24) . The cosmid cMB14 was next replaced by expression plasmids for the two genes, BSLF1 and BMRF1, that were potential homologs for HSV replication genes. Replication was positive in the presence of BSLF1 and BMRF1, although the replication signal was reduced compared with that obtained with cMB14 or cMSalC (Fig.  5B, lane 4) . Transfection of the three essential cosmids in the presence of the lytic-cycle transactivators served as the positive control (Fig. 5B, lane 1) . Removal of Zta from the transfection mix abolished detectable replication of the target and served as the negative control (Fig. 5B, lane 2) . In a parallel experiment, the cosmid cM302-21 was successfully replaced by expression plasmids for the two predicted replication genes that mapped within cM302-21, the DNA polymerase, BALF5, and BALF2, the putative singlestranded DNA-binding protein (Fig. 5C, lane 3) . If either BALF5 (Fig. 5C, lane 4) or BALF2 (Fig. 5C, lane 5) was omitted, replication of the target did not occur. Therefore, the cosmid cMB14 encodes only two essential replication proteins, BSLF1, the primase homolog, and BMRF1, the processivity factor. Similarly, the cosmid cM302-21 also encodes only two replication proteins, the DNA polymerase, BALF5, and BALF2, the single-stranded DNA-binding protein homolog.
ori-Lyt replication also requires BBLF4, BBLF2/3, and SailI-F. A diagram of the remaining essential cosmid, cM301-99, showing the map locations of relevant open reading frames is presented in Fig. 6A . The only gene encoded by cM301-99 which has recognized sequence homology to a replication protein of HSV-1 is BBLF4. However, when this cosmid was replaced by an expression plasmid for BBLF4, no detectable replication occurred (data not shown). Replication of the target was restored, however, if cM301-99 was replaced by the BBLF4 expression plasmid and two cM301-99 subclones, SalI-F and BamHI-BG, neither of which contains an intact BBLF4 open reading frame (Fig.  6B, lane 3) . Removal of either BamHI-BG (Fig. 6B, lane 4) or SalI-F (Fig. 6B, lane 5) abolished detectable replication of the target. The three cosmids plus transactivators again served as the positive control (Fig. 6B, lane 1) , while the negative control lacked Zta (Fig. 6B, lane 2) . Removal of BBLF4 also abolished detectable replication of the target (data not shown). Because two cM301-99 subclones and the BBLF4 expression plasmid were required to replace cM301-99, at least three replication genes appear to be provided by this cosmid.
To determine the gene or genes provided by BamHI-BG, we used subclones of this DNA fragment. The clone BamHIABAG(pJMH4) was able to substitute for BamHI-BG in the replication assay (Fig. 6C, lane 4) . Both BamHI-BG and BamHIABAG contain the two open reading frames BBLF2 and BBLF3 (Fig. 6A) , which are potential UL9 and UL8 homologs based on their genome locations (52) . The linkage with UL8 was further strengthened by the recognition that BBLF2 has a stretch of 55 amino acids which are A.
J. VIROL. We also demonstrated that the combination of these six genes plus Sail-F and the Zta, Rta, and Mta transcriptional transactivators were sufficient to support replication of oriLyt (Fig. 8, lane 4) . In an earlier experiment (Fig. 4) , we demonstrated that Rta and Zta were both required for replication. To address the question of the requirement for the Mta transactivator, we used the set of six cloned genes plus Sall-F. As shown in Fig. 8 (lane 5) , replication of ori-Lyt was significantly reduced but not eliminated in the absence of added Mta, even though both Zta and Rta were present. Therefore, all three transactivators appear to be necessary for maximal replication.
Finally, our standard ori-Lyt target was the BamHI-H fragment, which contains an intact BHLF1 gene in addition to ori-Lyt (Fig. 1) . Since a plasmid with this open reading frame was present in all the replication assays shown, the potential existed for the BHLF1 gene product to be contributing to ori-Lyt replication. To address this question, we substituted a modified BamHI-H target (pPL2A) carrying a 1,375-bp deletion in the BHLF1 open reading frame for BamHI-H. This modified ori-Lyt target was still replication competent when cotransfected with the six cloned replication genes, plus SalI-F and the three transactivators, indicating that BHLF1 is not essential (Fig. 8, lane 1) .
DISCUSSION
The identity of the virally encoded trans-acting proteins involved in HSV DNA replication was established through a combination of genetic studies and the use of transient cotransfection-replication assays. Several of the HSV replication genes have potential homologs in EBV based on sequence similarities. However, with the exception of the EBV DNA polymerase (BALF5) and the associated polymerase processivity factor (BMRF1), the functional equivalence of these genes has not previously been examined, nor has the full complement of genes required for lytic EBV DNA replication been determined. We established a cotransfection-replication assay utilizing Vero cells and overlapping cosmid clones of the EBV genome to examine the requirements for replication of an ori-Lyt-containing target plasmid. Our studies identified six EBV genes, BALF5, BMRF1, BALF2, BBLF4, BSLF1, and BBLF2/3, along with the viral lytic-cycle transactivators, Zta, Rta, and Mta, and an unidentified gene in SalI-F, as being essential for ori-Lyt replication in the transient assay.
Two of the essential genes, the DNA polymerase and the polymerase processivity factor, were already known to serve a replication function. The first evidence for an EBVencoded polymerase came from studies demonstrating that VOL. 66, 1992 on viral lytic-cycle replication was selectively inhibited by drugs such as phosphonoacetic acid and acyclovir (16, 45) . Sequencing of the EBV genome revealed an open reading frame (BALF5) whose protein product shares 33% sequence identity with the HSV DNA polymerase (3, 52) and like the HSV polymerase has several regions that are highly conserved in prokaryotic and eukaryotic viral DNA polymerases and in mammalian DNA polymerase alpha (64) . More recently, BALF5 has been synthesized in vitro and shown to exhibit polymerase activity (50) . The BMRF1 gene is the positional equivalent of the HSV UL42 polymerase processivity factor (20, 27, 29, 36) . Although the EBV protein has no significant sequence similarity to UILA2, it is a functional homolog. The BMRF1 protein copurifies with the EBV polymerase and has been shown to stimulate polymerase activity in vitro (40, 46) .
The four other EBV genes identified as being required for ori-Lyt replication in the cotransfection-replication assay are BALF2, BBLF4, BSLF1, and BBLF2/3. The BALF2 gene product has 25% overall identity with the HSV singlestranded DNA-binding protein (UL29). BALF2 also contains a series of motifs that are highly conserved in the HSV, VZV, SCMV, and HCMV single-stranded DNA-binding proteins (1, 10, 65) . The HSV and EBV proteins are virtually identical in size at 1,196 and 1,128 amino acids, respectively. The BBLF4 and BSLF1 proteins have significant sequence identity with the HSV UL5 and UL52 genes. UL5 and UL52 form a tripartite complex with UL8 in HSV-infected cells and in insect cells coinfected with recombinant baculoviruses expressing these genes (15, 21) . This complex has both helicase and primase activities. Recently, helicase and pri- (23, 41, 54) . Since ori-Lyt is unrelated in sequence to HSV ori-S and ori-L, it is not surprising that comparative analyses have not revealed a homolog for UL9. It is possible that the gene for the EBV origin-binding protein is located in SalI-F or that one of the proteins already shown to be required in the cotransfection assay is multifunctional and also provides origin-binding activity. Another alternative is that the originbinding protein is not virally encoded and that a cellular factor serves in this capacity.
The EBV-encoded proteins identified in this study as being required for ori-Lyt replication are homologs of HSV proteins that participate directly in DNA replication. Herpesviruses also encode a number of enzymes, alkaline nuclease, ribonucleotide reductase, thymidine kinase, dUTPase, and uracil DNA glycosylase, that are involved in nucleotide metabolism and play an ancillary role in DNA synthesis (reviewed in reference 66). Genetic studies with HSV indicate that under certain conditions such as growth at high temperature, in growth-arrested cells, or in the animal host, HSV DNA replication may become dependent on the virally encoded alkaline nuclease, thymidine kinase, and ribonucleotide reductase. In our cotransfection-replication assays, the cosmid cMB14 could be replaced by a cosmid cMSalC which has five open reading frames in common with cMB14. The common genes are BMRF1 (the polymerase processivity factor), BSLF1 (the putative primase homolog), BMLF1 (the Mta transactivator), BMRF2, BORF2, and BaRF1. When these cosmids were replaced by expression vectors for BMRF1 and BSLF1, replication of ori-Lyt did occur but at a reduced level. This observation raises the possibility that cMB14 and cMSalC were providing an additional nonessential, replication-related function. Mta can be discounted since it was being provided exogenously by an expression vector, and BMRF2 is a late gene and therefore not a likely candidate for a replication-related function. The remaining common open reading frames, BORF2 and BaRF1, encode the large and small subunits of ribonucleotide reductase. One interpretation of the data is that the EBV-encoded ribonucleotide reductase is providing an auxiliary function that increases replication efficiency in these assays. The replication signal was also reduced when the BamHI-H ori-Lyt target was replaced with a modified target carrying a deletion in the BHLF1 gene. In this case, the apparent reduction in replication efficiency may simply represent decreased hybridization of the probe to the target DNA which no longer contains the NotI repeats.
The minimal ori-Lyt as defined by Hammerschmidt and Sugden (32) consists of three essential subdomains (Fig. 1) . Two of these, the BHLF1 promoter and the upstream enhancer, also function in transcriptional regulation of the flanking BHLF1 and BHRF1 genes. Characterized replication origins are commonly associated with transcriptional elements (reviewed in reference 19) . These elements may be integrally linked to replication functions or may serve an auxiliary role by contributing to replication efficiency. For example, the cloned minimal HSV-1 origin, ori-S, can function in transient replication assays. However, if the flanking sequences containing the divergent promoters for the immediate-early IE175 and IE68 genes are also included, replication of the target is substantially increased (69) . The EBV latency origin of replication (ori-P) consists of two domains, an EBNA-1-dependent enhancer and a region of dyad symmetry that is the site of initiation of replication (26, 72 (31, 48) . The enhancer is strongly activated by Rta and responds synergistically to the combination of Rta and Zta (14) . In the cotransfection-replication assays, ori-Lyt replication was dependent on the presence of Zta, Rta, and Mta. In the assays using the cosmid clones, the transactivators would have been required for efficient expression of the replication genes encoded within the cosmids. Even in the final assays described here, at least one of the genes necessary for replication was provided on Sail-F, and again it is likely that the transactivators would be needed for expression from this plasmid. In HSV, the immediate-early transactivators were required for replication of ori-S in the transient replication assay when viral DNA fragments were used to provide the replication functions. In contrast, when each of the seven replication genes was expressed from the strong constitutive HCMV promoter, the requirement for these transcription factors in the transient replication assay was alleviated (35) . In EBV, however, the inclusion of the promoter and enhancer elements within the defined limits of the minimal ori-Lyt makes it highly probable that Zta and Rta contribute to replication directly through transcriptional activation, through DNA binding, or through interactions with components of the replication complex. The role of these transactivators in ori-Lyt replication can be addressed VOL. 66, 1992 on November 7, 2017 by guest http://jvi.asm.org/ Downloaded from more directly when the full complement of EBV replication genes has been identified.
